High Blood Pressure (Hypertension)

Blood pressure rises naturally in response to a clogging of your blood vessels in order to deliver oxygen and nutrients to your body. The pharmaceutical industry’s answer is to inhibit the natural mechanisms of the body, causing the pressure to fall. The problem with this artificial reduction of pressure is that nothing helpful has been accomplished by the medication to improve the health of the blood vessels themselves. The arteries remain fragile and ready to burst into a stroke or heart attack. Attacking the cause of the problem – the rich Western diet – cleans up and strengthens the blood vessels and reduces the resistance to blood flow. Your blood pressure will then fall naturally. In less than 2 weeks of following the McDougall Program, people with high blood pressure (150/90 mmHg or greater) experience an average reduction of 23/14 mmHg and in most cases significantly reduce or stop all blood pressure medications.

Canadians have heart disease

Few Canadians have good heart health

A new study finds nine per cent of Canadian adults meet the criteria for “ideal” cardiovascular health.

Photograph by: Jason Kryk, Postmedia News File Photo , Postmedia News

A paltry nine per cent of Canadian adults – fewer than one in 10 – meet the criteria for “ideal” cardiovascular health, a new study based on nearly half a million Canadians says.

The heart health of the nation’s youth is only marginally better, with only 17 per cent of those aged 12 to 19 – fewer than one in five – getting top scores for healthy behaviours.

Huge Study Of Diet Indicts Fat And Meat

By JANE E. BRODY
Published: May 08, 1990

EARLY findings from the most comprehensive large study ever undertaken of the relationship between diet and the risk of developing disease are challenging much of American dietary dogma. The study, being conducted in China, paints a bold portrait of a plant-based eating plan that is more likely to promote health than disease.

The study can be considered the Grand Prix of epidemiology. Sixty-five hundred Chinese have each contributed 367 facts about their eating and other habits that could ultimately help them and Americans preserve their health and prolong their lives. The data alone fill a volume of 920 pages, to be published next month by Cornell University Press. Among the first tantalizing findings are these: Obesity is related more to what people eat than how much. Adjusted for height, the Chinese consume 20 percent more calories than Americans do, but Americans are 25 percent fatter. The main dietary differences are fat and starch. The Chinese eat only a third the amount of fat Americans do, while eating twice the starch. The body readily stores fat but expends a larger proportion of the carbohydrates consumed as heat. Some of the differences may be attributable to exercise. The varying levels of physical activity among the Chinese were measured, but the data have not yet been analyzed.

Reducing dietary fat to less than 30 percent of calories, as is currently recommended for Americans, may not be enough to curb the risk of heart disease and cancer. To make a significant impact, the Chinese data imply, a maximum of 20 percent of calories from fat – and preferably only 10 to 15 percent – should be consumed.

Eating a lot of protein, especially animal protein, is also linked to chronic disease. Americans consume a third more protein than the Chinese do, and 70 percent of American protein comes from animals, while only 7 percent of Chinese protein does. Those Chinese who eat the most protein, and especially the most animal protein, also have the highest rates of the ”diseases of affluence” like heart disease, cancer and diabetes.

A rich diet that promotes rapid growth early in life may increase a woman’s risk of developing cancer of the reproductive organs and the breast. Childhood diets high in calories, protein, calcium and fat promote growth and early menarche, which in turn is associated with high cancer rates. Chinese women, who rarely suffer these cancers, start menstruating three to six years later than Americans. Dairy calcium is not needed to prevent osteoporosis. Most Chinese consume no dairy products and instead get all their calcium from vegetables. While the Chinese consume only half the calcium Americans do, osteoporosis is uncommon in China despite an average life expectancy of about 70 years, just five few years less than the American average.

These findings are only the beginning. Dr. T. Colin Campbell, a nutritional biochemist from Cornell University and the American mastermind of the Chinese diet study, predicts that this ”living laboratory” will continue to generate vital findings for the next 40 to 50 years.

The study, started in 1983 to explore dietary causes of cancer, has been expanded to include heart, metabolic and infectious diseases. Dr. Chen Junshi of the Chinese Institute of Nutrition and Food Hygiene organized the survey to cover locations from the semitropical south to the cold, arid north.

Exacting, Labor-Intensive Study

The extensive volume of raw data and its counterpart on computer tape will be available to any scientist to use as raw material for medical research.

It is an exacting, labor-intensive study, initially financed by the National Cancer Institute, that probably could not have been done anywhere except China. For nowhere else can accurate mortality statistics be combined with data from people who live the same way in the same place and eat the same foods for virtually their entire lives.

Nowhere else is there a genetically similar population with such great regional differences in disease rates, dietary habits and environmental exposures. For example, cancer rates can vary by a factor of several hundred from one region of China to another. These large regional variations in China highlight biologically important relationships between diet and disease.

And nowhere else could researchers afford to hire hundreds of trained workers to collect blood and urine samples and spend three days in each household gathering exact information on what and how much people eat, then analyzing the food samples for nutrient content.

‘The Whole Diet Panoply’

”The total cost in U.S. dollars of this project – $2.3 million plus 600 person-years of labor contributed by the Chinese Government – is a mere fraction of what it would have cost to do the same study here,” Dr. Campbell noted. And unlike typically circumscribed American studies that examine one characteristic as a factor in one disease, the Chinese investigation ”covers the whole diet panoply as it relates to all diseases.”

Dr. Mark Hegsted, emeritus professor of nutrition at Harvard University and former administrator of human nutrition for the United States Department of Agriculture, said: ”This is a very, very important study – unique and well done. Even if you could pay for it, you couldn’t do this study in the United States because the population is too homogeneous. You get a lot more meaningful data when the differences in diet and disease are as great as they are in the various parts of China.”

In the first part of the study, 100 people from each of 65 counties throughout China each contributed 367 items of information about their diets, lives and bodies. The responses from residents of each county were then pooled to derive countywide characteristics that could be measured against the area’s death rates for more than four dozen diseases.

By matching characteristics, researchers derived 135,000 correlations, about 8,000 of which are expected to have both statistical and biological significance that could shed light on the cause of some devastating disease.

In the poorer parts of China, infectious diseases remain the leading causes of death, but in the more affluent regions, heart disease, diabetes and cancer are most prominent, Dr. Campbell said.

Adding Taiwan to the Research

Although from an overall perspective of nutrient composition the Chinese diet is more health-promoting than ours, he said, there are some important limitations that result from a lack of economic development.

”Food quality and variety are not as good as ours,” he explained. ”With limited refrigeration, bacteria and mold contamination is more common, large amounts of salt and nitrites are used to preserve foods and hot spices are used to mask off-flavors.”

The study is now being expanded and revised. New mortality rates are being gathered to update the original mortality data from the early 1970’s and to reflect causes of death for 100 million people in the late 1980’s. The original 6,500 participants are being resurveyed and people from 12 counties in Taiwan are being included in the expanded survey, which will also measure many socioeconomic characteristics.

”We want to see how economics change and health factors follow,” Dr. Campbell explained in an interview. ”Taiwan should be interesting because it is intermediate between the United States and China in nutrient intake and plasma cholesterol levels. And since the Taiwanese gene pool is more like the Chinese, we can study the relative contributions of genetics and diet to risk of disease.”

Cholesterol as Disease Predictor

Dr. Campbell continued: ”So far we’ve seen that plasma cholesterol is a good predictor of the kinds of diseases people are going to get. Those with higher cholesterol levels are prone to the diseases of affluence – cancer, heart disease and diabetes.”

Contrary to earlier reports that linked low blood cholesterol levels to colon cancer, the Chinese study strongly suggests that low cholesterol not only protects against heart disease but also protects against cancer of the colon, the most common life-threatening cancer among Americans. In China, mortality rates from colon cancer are lowest where cholesterol levels are lowest.

Over all, cholesterol levels in China, which range from 88 to 165 milligrams per 100 milliliters of blood plasma, much lower than those in the United States, which range from 155 to 274 milligrams per 100 milliliters of plasma.

”Their high cholesterol is our low,” Dr. Campbell noted. He said the data strongly suggest that a major influence on cholesterol levels and disease rates is the high consumption of animal foods, including dairy products, by Americans.

‘Basically a Vegetarian Species’

”We’re basically a vegetarian species and should be eating a wide variety of plant foods and minimizing our intake of animal foods,” he said.

The Chinese have already begun to capitalize on these findings, using them to develop national food and agricultural policies that will promote health.

”Usually, the first thing a country does in the course of economic development is to introduce a lot of livestock,” Dr. Campbell said. ”Our data are showing that this is not a very smart move, and the Chinese are listening. They’re realizing that animal-based agriculture is not the way to go.”

The plant-rich Chinese diet contains three times more dietary fiber than Americans typically consume. The average intake in China is 33 grams of fiber a day, and it ranges as high as 77 grams in some regions. Dr. Campbell found no evidence to suggest that diets very high in fiber are in any way deleterious to nutritional well-being.

While American scientists worry that fiber may interfere with the absorption of essential minerals like iron, no reason for concern was found among the Chinese. Rather, those with the highest fiber intake also had the most iron-rich blood.

Iron From Vegetables

The study also showed that consumption of meat is not needed to prevent iron-deficiency anemia. The average Chinese adult, who shows no evidence of anemia, consumes twice the iron Americans do, but the vast majority of it comes from the iron in plants.

Nor are animal products needed to prevent osteoporosis, the study showed. ”Ironically,” Dr. Campbell noted, ”osteoporosis tends to occur in countries where calcium intake is highest and most of it comes from protein-rich dairy products. The Chinese data indicate that people need less calcium than we think and can get adequate amounts from vegetables.”

Another common health concern that could prove to be a red herring is the fear that aflatoxin, which is produced by a mold that grows on peanuts, corn and other grains, causes liver cancer. Rather, the Chinese study strongly indicates that chronic infection with hepatitis B virus and high serum cholesterol levels are the primary culprits.

”We did not find any relationship between aflatoxin and liver cancer, and we have the largest study on this question ever done,” Dr. Campbell said.

Among other intriguing findings are a relationship between infection with herpes simplex virus and coronary heart disease and a relationship between infection with the yeast candida and nasopharyngeal cancer.

”Lots and lots such relationships are turning up as we plot out the 367 characteristics on maps of China and try to match them up with maps of disease rates,” Dr. Campbell said. ”The data now need to be interpreted, and six Chinese scientists are working with us on this. The amount of information gathered in this study is kind of staggering,” he said, then proceeded to outline his interest in gathering more.

Fats: The Good the Bad and the Ugly

Health Canada

http://www.hc-sc.gc.ca

Health Canada- states, unsaturated fats (plant-based) are good and saturated (animal-based) are bad.

The good: unsaturated fats

Unsaturated fat is a type of fat found in the foods you eat. Replacing saturated and trans fats with unsaturated fats has been shown to help lower cholesterol levels and reduce the risk of heart disease. Unsaturated fat also provides omega-3 and -6 fatty acids. Choose foods with unsaturated fat as part of a balanced diet using Eating Well with Canada’s Food Guide.

Even though it is a “good fat,” having too much unsaturated fat may lead to having too many calories. This may cause weight gain and increase your risk of developing obesitytype 2 diabetesheart disease and certain types of Next link will take you to another Web site cancer.

There are two main types of unsaturated fats:

  1. monounsaturated fat, which can be found in:
    • avocados
    • nuts and seeds (like cashews, pecans, almonds and peanuts)
    • vegetable oils (like canola, olive, peanut, safflower, sesame and sunflower)
  2. polyunsaturated fat, which can be found in:
    • fatty fish (like herring, mackerel, salmon, trout and smelt)
    • fish oils
    • nuts and seeds (like cashews, pecans, almonds and peanuts)
    • vegetable oils (like canola, corn, flaxseed, soybean and sunflower)

The bad: saturated fats

Saturated fat is a type of fat found in food. It has been shown to raiseLDL or “bad” cholesterol levels. Having high LDL-cholesterol levels increases your risk for heart disease.

Saturated fat is found in many foods:

  • animal foods (like beef, chicken, lamb, pork and veal)
  • coconut, palm and palm kernel oils
  • dairy products (like butter, cheese and whole milk)
  • lard
  • shortening

Choosing lower-fat meat and dairy products can help reduce the amount of saturated fat in your diet.

Use vegetable oil or soft margarines that are low in saturated and trans fats instead of butter, hard margarine, lard and shortening.

The ugly: trans fats

Trans fat is made from a chemical process known as “partial hydrogenation.” This is when liquid oil is made into a solid fat.

Like saturated fat, trans fat has been shown to raise LDL or “bad” cholesterol levels, which increases your risk for heart disease. Unlike saturated fat, trans fat also lowers HDL or “good” cholesterol. A low level of HDL-cholesterol is also a risk factor for heart disease.

Until recently, most of the trans fat found in a typical Canadian diet came from:

  • margarines (especially hard margarines)
  • commercially fried foods
  • bakery products made with shortening, margarine or oils containing partially hydrogenated oils and fats (including cakes, cookies, crackers, croissants, doughnuts, fried and breaded foods, muffins, pastries and other snack foods)

If a product has less than 0.2 grams of trans fat AND less than 0.5 g of saturated fat, the food manufacturer can say that the product is trans-fat-free. Learn more about nutrition claims.

Our food supply is rapidly changing and the trans fat content of many of these products has now been reduced. But it is still important to look at the Nutrition Facts table to make sure the food product you are buying has only a little or no trans fat.

http://www.hc-sc.gc.ca/hl-vs/iyh-vsv/med/fats-gras-eng.php

What’s Wrong with Eggs?

By    |   Posted on September 3, 2013 

 

Whats wrong with eggs 570x299 What’s Wrong with Eggs?A common question I hear as a dietitian (second only to “Where do you get your protein?” of course) is “What’s wrong with eggs?”

Where to begin? Let’s start with the obvious egg facts. Eggs have zero dietary fiber, and about 70 percent of their calories are from fat—a big portion of which is saturated. They are also loaded with cholesterol—about 213 milligrams for an average-sized egg. For reference, people with diabetes, cardiovascular disease, or high cholesterol should consume fewer than 200 milligrams of cholesterol each day. (Uh oh.) And, humans have no biological need to consume any cholesterol at all; we make more than enough in our own bodies.

 

Why so much fat and cholesterol in such a tiny package? Think about it: eggs hold every piece of the puzzle needed to produce a new life. Within that shell lies the capacity to make feathers, eyes, a beak, a brain, a heart, and so on. It takes a lot of stuff to make such a complex being.

In addition to these excessive (for humans) natural components of an egg, other human-health hazards exist. Because eggshells are fragile and porous, and conditions on egg farms are crowded, eggs are the perfect host for salmonella—the leading cause of food poisoning in the U.S.

Those are some facts and figures. But how do eggs affect real people in real life? Luckily, researchers have conducted good studies to help answer that question.

Cancer

In a 1992 analysis of dietary habits, people who consumed just 1.5 eggs per week had nearly five times the risk for colon cancer, compared with those who consumed hardly any (fewer than 11 per year), according to the International Journal of Cancer. The World Health Organization analyzed data from 34 countries in 2003 and found that eating eggs is associated with death from colon and rectal cancers. And a 2011 study funded by the National Institutes of Healthshowed that eating eggs is linked to developing prostate cancer. By consuming 2.5 eggs per week, men increased their risk for a deadly form of prostate cancer by 81 percent, compared with men who consumed less than half an egg per week. Finally, even moderate egg consumption tripled the risk of developing bladder cancer, according to a 2005 study published in International Urology and Nephrology.

Diabetes

A review of fourteen studies published earlier this year in the journalAtherosclerosis showed that people who consumed the most eggs increased their risk for diabetes by 68 percent, compared with those who ate the fewest.

In a 2008 publication for the Physicians’ Health Study I, which included more than 21,000 participants, researchers found that those who consumed seven or more eggs per week had an almost 25 percent increased risk of death compared to those with the lowest egg consumption. The risk of death for participants with diabetes who ate seven or more eggs per week was twice as high as for those who consumed the least amount of eggs.

Egg consumption also increases the risk of gestational diabetes, according to two 2011 studies referenced in the American Journal of Epidemiology. Women who consumed the most eggs had a 77 percent increased risk of diabetes in one study and a 165 percent increased risk in the other, compared with those who consumed the least.

Heart Disease

Researchers published a blanket warning in the Canadian Journal of Cardiology, informing readers that ceasing egg consumption after a heart attack would be “a necessary act, but late.” In the previously mentioned 14-study review, researchers found that people who consumed the most eggs increased their risk for cardiovascular disease by 19 percent, and if those people already had diabetes, the risk for developing heart disease jumped to 83 percent with increased egg consumption.

New research published this year has shown that a byproduct of choline, a component that is particularly high in eggs, increases one’s risk for a heart attack, stroke, and death.

Animal Protein

Inevitably, this discussion also leads to another question: “Even egg whites?” Yes, even egg whites are trouble. The reason most people purport to eat egg whites is also the reason they should be wary — egg whites are a very concentrated source of animal protein (remember, the raw material for all those yet-to-be-developed body parts?). Because most Westerners get far more protein than they need, adding a concentrated source of it to the diet can increase the risk for kidney disease, kidney stones, and some types of cancer.

By avoiding eggs and consuming more plant-based foods, you will not only decrease your intake of cholesterol, saturated fat, and animal protein, but also increase your intake of protective fiber, antioxidants, and phytochemicals. Be smart! Skip the eggs and enjoy better health!

Susan Levin, M.S., R.D.

Susan Levin, M.S., R.D.

Susan Levin, M.S., R.D., is director of nutrition education at the Physicians Committee for Responsible Medicine (PCRM), a Washington, D.C.-based nonprofit organization dedicated to promoting preventive medicine. Ms. Levin researches and writes about the connection between plant-based diets and a reduced risk of chronic diseases, including cancer, diabetes, and heart disease.

Brain Impairment from the Atkins Diet

John McDougall, MD


Dr John McDougall

Brain Impairment from the Atkins Diet

 

 

 

 

Low-carbohydrate weight-loss diets. Effects on cognition and mood by Kristen D’Anci in the February 2009 issue of the journal Appetite concluded that,The present data show memory impairments during low-carbohydrate diets at a point when available glycogen stores would be at their lowest.” Women followed a low-carbohydrate diet, similar to the Atkins diet, or a reduced-calorie balanced diet, similar to that recommended by the American Dietetic Association (ADA). “Results showed that during complete withdrawal of dietary carbohydrate, low-carbohydrate dieters performed worse on memory-based tasks than ADA dieters. These impairments were ameliorated after reintroduction of carbohydrates.”  After about one week of severe carbohydrate deprivation subjects demonstrated impairment of memory.

Comments:  Have you noticed any of your dieting friends slipping with their physical or mental health?  There are scientific reasons to believe this is a real change caused by a deficiency of “brain fuel,” which is carbohydrate. Sugar (glucose) is the primary, preferred fuel for the brain and it is not stored in the brain tissues.  Thus, the brain is dependent upon circulating glucose in the blood stream.  This glucose comes almost exclusively from eating carbohydrates.  Except for milk and honey, only plant-derived foods contain carbohydrate. The body’s stores of carbohydrate last about 24 to 72 hours after starting on a low-carbohydrate, Atkins-type diet.  Upon depletion of carbohydrates the body metabolizes body fat into ketones, which can be used, but less efficiently, by the brain tissues and other body tissues for fuel.

The popularity of low-carbohydrate diets is waning, but I doubt they will vanish because they promise quick weight loss while consuming familiar foods like beef, butter and Brie.  These diets work by simulating sickness.  Without carbohydrate the body turns to fat for energy. Ketones are produced from fat metabolism and with their accumulation a condition of ketosis develops. Ketosis suppresses the appetite. Weight loss follows as long as ketosis-induced, appetite-suppression, is maintained. Most dieters cannot tolerate the unpleasantness of sickness for long and they give up, regaining all their lost body fat.

The foods consumed for a low-carbohydrate diet (meat, poultry, fish, cheese, eggs) are known to cause many serious illnesses, including heart disease, strokes, cancer, osteoporosis, and constipation.  This is not the right way to lose weight.

D’Anci KE, Watts KL, Kanarek RB, Taylor HA. Low-carbohydrate weight-loss diets. Effects on cognition and mood. Appetite. 2009 Feb;52(1):96-103.

Eggs Harmful to Health

BREAKING MEDICAL NEWS May 15, 2013

 

Eggs Harmful to Health

May 15, 2013 

Eggs increase the risk for heart disease and diabetes, according to a new meta-analysis published in Atherosclerosis. Researchers reviewed 14 studies and found that those who consumed the most eggs had a 19 and 68 percent increased risk for developing cardiovascular disease and diabetes, respectively, compared with those who ate the fewest eggs. For those who already had diabetes, the risk for developing heart disease from eating the most eggs jumped by 83 percent.

Li Y, Zhou C, Zhou X, Li L. Egg consumption and risk of cardiovascular diseases and diabetes: A meta-analysis. Atherosclerosis. Published ahead of print April 17, 2013.
Subscribe to PCRM’s Breaking Medical News.

Breaking Medical News is a service of the Physicians Committee for Responsible Medicine, 5100 Wisconsin Ave., Ste. 400, Washington, DC 20016, 202-686-2210. Join PCRM and receive the quarterly magazine,Good Medicine.

Is Heart Surgery Worth It?

By John Carey, with Amy Barrett You start breathing hard after climbing stairs, and your chest hurts. You go to your doctor. Scans reveal that arteries feeding your heart are severely narrowed. Your doctor sends you to the hospital for coronary bypass surgery or angioplasty to restore the blood flow to your heart. Despite the trauma of surgery, you’re glad the blockage was caught in time, saving you from a potentially fatal heart attack.

 

There’s just one problem with this happy tale of modern medicine: More and more doctors are questioning whether such heart procedures are actually extending patients’ lives. One of them, Dr. Nortin M. Hadler, professor of medicine at the University of North Carolina at Chapel Hill and author of The Last Well Person, is urging the U.S. medical establishment to rethink its most basic precepts of cardiovascular care. Bypass surgery in particular, he says, “should have been relegated to the archives 15 years ago.”

UNLIKE PLUMBING. That is an extreme view that is disputed by cardiac surgeons. “The reason thousands and thousands of bypass surgeries have been done is that [the procedure] is successful,” says Dr. Timothy J. Gardner, co-editor of Operative Cardiac Surgery and a cardiothoracic surgeon at Christiana Care Health System in Wilmington, Del.

 

Nevertheless, the data from clinical trials are clear: Except in a minority of patients with severe disease, bypass operations don’t prolong life or prevent future heart attacks. Nor does angioplasty, in which narrowed vessels are expanded and then, typically, propped open with metal tubes called stents.

 

“People often believe that having these procedures fixes the problem, as if a plumber came in and fixed the plumbing with a new piece of pipe,” explains Dr. L. David Hillis, professor of cardiology at the University of Texas Southwestern Medical School. “But it fundamentally doesn’t fix the problem.”

IMAGE OF INVINCIBILITY. With doctors doing about 400,000 bypass surgeries and 1 million angioplasties a year — part of a heart-surgery industry worth an estimated $100 billion a year — the question of whether these operations are overused has enormous medical and economic implications. “It is one of the major issues in cardiology right now,” says Dr. David Waters, chief of cardiology at the University of California at San Francisco.

 

It is also part of a far broader problem — what some health-care experts call the medicalization of life. “None of us will live long without headache, backache, heartache, heartburn, diarrhea, constipation, sadness, malaise, or other symptoms of some kind,” argues Hadler. Yet under relentless bombardment by messages from the pharmaceutical and health-care industries, Americans increasingly believe that these symptoms — and many others — are conditions that can and should be cured.

 

“We have an image of ourselves as invincible and powerful and able to overcome all odds,” Hadler says. “And the lay press is too quick to talk about the latest widget and gizmo without asking what it is and does it work.”

HIGHER COST, BIGGER RISK. Indeed, there is compelling evidence that more health care and more aggressive treatment across the complete spectrum of illnesses is not necessarily better. When Dr. Elliott S. Fisher, professor of medicine at Dartmouth Medical School, first looked at regional differences in health-care spending in the U.S., he assumed that people in areas with lower expenditures would have worse health than people in regions where spending was 1 1/2 to 2 times as high because they were failing to receive needed care. It turned out that the opposite was true.

 

“Patients have a substantial increased risk of death if cared for in the high-cost systems,” he says. Why? For one thing, additional doctor visits and testing often lead to unnecessary procedures and hospitalizations, which carry risks. “My data suggest that we are wasting 30% of health-care spending on stuff with no benefit and perhaps causing harm,” says Fisher.

 

International comparisons support his reasoning. The U.S. spends 2 1/2 times as much as any other country per person on health care, but that doesn’t translate into better outcomes, according to studies that compare such indicators as fatality rates after a heart attack and length of survival after a kidney transplant. That suggests that “the investment in health care in the U.S. is just not paying off,” says Gerard Anderson, director of the Center for Hospital Finance & Management at Johns Hopkins Bloomberg School of Public Health and co-author of a 2004 study that looked at 21 different health-quality indicators in five nations.

LUCRATIVE CARDIAC UNITS. Similar comparisons can help pinpoint dubious treatments. The classic case: tonsillectomy. In the early 1970s, Dr. John E. Wennberg, now director of the Center for Evaluative Clinical Sciences at Dartmouth Medical School, showed that some hospitals removed tonsils 10 times as often as others. But the children in areas with low rates weren’t worse off, so the operation fell out of favor.

 

More recently, Dr. James N. Weinstein, chair of orthopedic surgery at Dartmouth-Hitchcock Medical Center, found that people with back pain are up to 20 times as likely to have back surgery in some parts of the country as in others. Yet it’s not clear that they do better as a result. Weinstein is comparing the outcomes in patients who get different treatments, from rest and physical therapy to spinal fusion. Meanwhile, he says, “billions of dollars are being spent without good information.”

 

This is of obvious concern to those who pay for health care, from the government to private insurers, which are struggling to better balance costs and benefits. And nowhere are the financial and health stakes higher than in the area of cardiac surgery. U.S. patients and insurers will spend $3.4 billion this year on drug-coated stents from suppliers Boston Scientific (BSX

) and Johnson & Johnson (JNJ

), according to Citigroup. At many hospitals, cardiac units have become major profit centers.

 

“We’ve shown that it is a lucrative area for hospitals,” says Paul B. Ginsburg, president of the Center for Studying Health System Change. But are heart procedures always the best path for patients who currently get them?

HEART ATTACK’S CAUSES. The answer seems to be no. As Hadler describes in his book, data from bypass-surgery clinical trials in the late 1970s show that the procedure extends life or prevents heart attacks only in a small percentage of patients — those with severe disease. More recent trials with angioplasty show it reduces deaths mainly just in emergencies.

 

“For people in the throes of heart attacks, opening the artery definitely prolongs life,” says UCSF’s Waters. Not so for patients with stable chronic disease. “The overwhelming number of heart procedures done these days do not affect patients’ life span at all,” says Hillis.

 

The latest thinking on heart attacks may explain why not. In the traditional view, the slow accumulation of plaque inside arteries gradually narrows the vessels. Reduced blood flow causes chest pain, or angina. Eventually the arteries are blocked, bringing on heart attacks. Newer evidence, however, pins the blame not on this gradual narrowing but on unstable plaque that breaks off and causes clots. The clots are what obstruct the arteries, causing the heart attacks — which is why so many such events are unexpected and why “there is no evidence that opening chronically narrowed arteries reduces the risk of heart attack,” says Waters.

DIET AND LIFESTYLE. A better way to lower heart-attack risk is to fight the unstable plaque with aggressive cholesterol-reducing drug therapy, diet, and lifestyle changes, many cardiac physicians say. That can be a tough sell to patients who want a quick fix, says Hillis.

 

“Medical therapy is just not as sexy as doing a procedure,” he explains. “The assumption our society makes is that the more aggressive your medical care is, the better it is. It’s not true. But if I explain to a patient why he doesn’t need surgery, 9 times out of 10 he will go across town and find someone who will do the procedure.”

 

The surgeries do relieve angina symptoms — and for some doctors that’s a slam dunk. Emory University cardiologist Dr. Robert A. Guyton, co-chair of the American College of Cardiology and the American Heart Assn. committee that wrote the current bypass-surgery guidelines, points to patients disabled by pain and shortness of breath who, a month after bypass surgery, “are walking around as healthy as you or I,” he says. “To say the whole operation ought to be scrapped is nuts.”

MAJOR PLACEBO EFFECT. Similarly, angioplasty eases the often crippling pain of angina. “There is quite a lot of good evidence for symptom relief,” says Dr. Robert Henderson, a cardiologist at Nottingham City Hospital in Britain and co-investigator for a key angioplasty clinical trial.

 

Critics such as Hadler, on the other hand, emphasize the risks. Not only is there a 1% to 2% chance of dying during a bypass operation, he explains, there is a high risk of complications and a 40% chance of cognitive deficits. The healthy, active post-surgery patient is an “urban legend,” he says. “An alarming number never return to the workforce or describe themselves as well again.”

 

Recent studies even raise questions about whether surgery causes the symptom relief. In June, Harvard Medical School associate professor of medicine Dr. Roger J. Laham reported on follow-up results of a randomized trial looking at laser surgery to improve blood flow. Patients who got the surgery had significantly less pain and improved heart function. But so did patients who had a sham operation — the equivalent of a placebo.

 

After 30 months the placebo effect was still there. Scans and other tests showed physiological gains in blood flow among only those who thought they had been operated on. A similar large placebo effect might explain “most of the benefits that we’ve seen so far with balloon angioplasty and bypass surgery,” Laham says.

CLOTS AND STENTS. There are also fresh concerns about the safety of drug-coated stents, now widely used in angioplasty. When doctors first tried to open clogged arteries with a balloon, they found that arteries soon closed again. So they began inserting metal mesh stents to hold them open. When arteries continued to clog up again, companies devised stents impregnated with drugs that slow the growth of cells, reducing chances that patients would have to have their arteries opened again.

 

First approved in April, 2003, drug-coated stents account for 88% of the stents used in the U.S. But when pathologist Dr. Renu Virmani, medical director of CVPath, a research service of the International Registry of Pathology, examined the hearts or heart vessels of 39 patients who died after getting the new stents, she found clots in 11 cases that developed more than 30 days after the procedure.

 

The sample is small, and it’s not clear that the clots caused the deaths. But it’s a big jump from her experience with patients who died after getting bare-metal stents. Just 12.5% of them had late-developing clots.

SURGERY VS. DRUGS. What worries some doctors is that people getting the new stents might have a higher risk of clots, which then could cause heart attacks more than a month after the procedure. “Out of 100 patients who get a drug-coated stent vs. a bare-metal stent, maybe 10 will avoid a repeat procedure,” says Dr. Eric J. Topol, chief of cardiology at the Cleveland Clinic Foundation. “But how many will wind up with a heart attack or death? Maybe one in 1,000? We just don’t have that nailed down yet.” Drug-coated stentmakers Boston Scientific and Johnson & Johnson say their clinical trials show no such increased risk of late-developing clots.

 

Cardiac surgeons readily admit there are big unanswered questions. “We can handle the criticisms, and we should be accountable,” says cardiothoracic surgeon Gardner. “But there is plenty of hard work going on to try to determine the appropriate patients for whom such treatments are necessary.” There are also large clinical trials under way comparing surgery with cholesterol-reducing drugs and other medical treatment, which will provide better answers.

 

If the trials show no benefit to surgery compared to medicine, “it will be a serious challenge to the coronary-intervention industry,” says Dr. Robert H. Jones, distinguished professor of cardiothoracic surgery at Duke University Medical Center. His prediction? “I’m a surgeon, so I think surgery will hold up.”

VITAL INFORMATION. The answers still may not be definitive, however, because medicine continues to advance. “Every time these studies come out and show that revascularization [improving blood flow] doesn’t do much, cardiologists say: ‘Well, that study was started four years ago, and now we have shinier stents, and the results are better,'” notes UCSF’s Waters. “But medical therapy [with drugs] is getting much, much better, too.”

 

Harvard’s Laham suggests that as many as 400,000 of the angioplasties done in the U.S. each year may be medically unwarranted. “I’m sure we are way overtreating our patients,” he says.

 

Some scientists argue that the rational solution is to let patients decide for themselves. But that requires providing detailed information about the risks and benefits of medical procedures, such as coronary surgery — including the unknowns. In trials where one group gets the information and the other group receives no special attention, the well-informed patients opt for more invasive, aggressive approaches 23% less often, on average, than the other group.

 

Without this full information, “patients typically don’t understand that they have options, and even if they do, they often wildly exaggerate the benefits of surgery and wildly minimize the chances of harm,” says Annette M. Cormier O’Connor, clinical epidemiologist at Ottawa Health Research Institute and a leader in this field of so-called decision aids.

MEDICINE’S LIMITATIONS. It’s a model approach for medicine in general. As Hadler argues, the exaggeration regarding benefits goes far beyond heart surgery. Too many common conditions are viewed as diseases needing treatment, and too many treatments of uncertain benefit are used too often. “What Hadler does is question the soundness of that thinking in a very profound way,” says Dr. Glenn D. Pomerantz, senior vice-president for global innovation at Cigna.

 

Hadler hopes that enlightening people about the limitations of medicine will help them worry less and stay well longer. It also could help cure an ailing health-care system, making it more rational. In the end, few doctors will object to the basic prescription: Avoid drastic procedures that probably won’t help and might actually do harm.

 

Carey is a senior correspondent for BusinessWeek in Washington, and Barrett is BusinessWeek’s Philadelphia bureau chief

Is Sugar Toxic?

Kenji Aoki for The New York Times
By GARY TAUBES
Published: April 13, 2011
 On May 26, 2009, Robert Lustig gave a lecture called “Sugar: The Bitter Truth,” which was posted on YouTube the following July. Since then, it has been viewed well over 800,000 times, gaining new viewers at a rate of about 50,000 per month, fairly remarkable numbers for a 90-minute discussion of the nuances of fructose biochemistry and human physiology.
Multimedia

What the average American consumes in added sugars:

Kenji Aoki for The New York Times

Lustig is a specialist on pediatric hormone disorders and the leading expert in childhood obesity at the University of California, San Francisco, School of Medicine, which is one of the best medical schools in the country. He published his first paper on childhood obesity a dozen years ago, and he has been treating patients and doing research on the disorder ever since.

The viral success of his lecture, though, has little to do with Lustig’s impressive credentials and far more with the persuasive case he makes that sugar is a “toxin” or a “poison,” terms he uses together 13 times through the course of the lecture, in addition to the five references to sugar as merely “evil.” And by “sugar,” Lustig means not only the white granulated stuff that we put in coffee and sprinkle on cereal — technically known as sucrose — but also high-fructose corn syrup, which has already become without Lustig’s help what he calls “the most demonized additive known to man.”

It doesn’t hurt Lustig’s cause that he is a compelling public speaker. His critics argue that what makes him compelling is his practice of taking suggestive evidence and insisting that it’s incontrovertible. Lustig certainly doesn’t dabble in shades of gray. Sugar is not just an empty calorie, he says; its effect on us is much more insidious. “It’s not about the calories,” he says. “It has nothing to do with the calories. It’s a poison by itself.”

If Lustig is right, then our excessive consumption of sugar is the primary reason that the numbers of obese and diabetic Americans have skyrocketed in the past 30 years. But his argument implies more than that. If Lustig is right, it would mean that sugar is also the likely dietary cause of several other chronic ailments widely considered to be diseases of Western lifestyles — heart disease, hypertension and many common cancers among them.

The number of viewers Lustig has attracted suggests that people are paying attention to his argument. When I set out to interview public health authorities and researchers for this article, they would often initiate the interview with some variation of the comment “surely you’ve spoken to Robert Lustig,” not because Lustig has done any of the key research on sugar himself, which he hasn’t, but because he’s willing to insist publicly and unambiguously, when most researchers are not, that sugar is a toxic substance that people abuse. In Lustig’s view, sugar should be thought of, like cigarettes and alcohol, as something that’s killing us.

This brings us to the salient question: Can sugar possibly be as bad as Lustig says it is?

It’s one thing to suggest, as most nutritionists will, that a healthful diet includes more fruits and vegetables, and maybe less fat, red meat and salt, or less of everything. It’s entirely different to claim that one particularly cherished aspect of our diet might not just be an unhealthful indulgence but actually be toxic, that when you bake your children a birthday cake or give them lemonade on a hot summer day, you may be doing them more harm than good, despite all the love that goes with it. Suggesting that sugar might kill us is what zealots do. But Lustig, who has genuine expertise, has accumulated and synthesized a mass of evidence, which he finds compelling enough to convict sugar. His critics consider that evidence insufficient, but there’s no way to know who might be right, or what must be done to find out, without discussing it.

If I didn’t buy this argument myself, I wouldn’t be writing about it here. And I also have a disclaimer to acknowledge. I’ve spent much of the last decade doing journalistic research on diet and chronic disease — some of the more contrarian findings, on dietary fat, appeared in this magazine —– and I have come to conclusions similar to Lustig’s.

The history of the debate over the health effects of sugar has gone on far longer than you might imagine. It is littered with erroneous statements and conclusions because even the supposed authorities had no true understanding of what they were talking about. They didn’t know, quite literally, what they meant by the word “sugar” and therefore what the implications were.

So let’s start by clarifying a few issues, beginning with Lustig’s use of the word “sugar” to mean both sucrose — beet and cane sugar, whether white or brown — and high-fructose corn syrup. This is a critical point, particularly because high-fructose corn syrup has indeed become “the flashpoint for everybody’s distrust of processed foods,” says Marion Nestle, a New York University nutritionist and the author of “Food Politics.”

This development is recent and borders on humorous. In the early 1980s, high-fructose corn syrup replaced sugar in sodas and other products in part because refined sugar then had the reputation as a generally noxious nutrient. (“Villain in Disguise?” asked a headline in this paper in 1977, before answering in the affirmative.) High-fructose corn syrup was portrayed by the food industry as a healthful alternative, and that’s how the public perceived it. It was also cheaper than sugar, which didn’t hurt its commercial prospects. Now the tide is rolling the other way, and refined sugar is making a commercial comeback as the supposedly healthful alternative to this noxious corn-syrup stuff. “Industry after industry is replacing their product with sucrose and advertising it as such — ‘No High-Fructose Corn Syrup,’ ” Nestle notes.

But marketing aside, the two sweeteners are effectively identical in their biological effects. “High-fructose corn syrup, sugar — no difference,” is how Lustig put it in a lecture that I attended in San Francisco last December. “The point is they’re each bad — equally bad, equally poisonous.”

Refined sugar (that is, sucrose) is made up of a molecule of the carbohydrate glucose, bonded to a molecule of the carbohydrate fructose — a 50-50 mixture of the two. The fructose, which is almost twice as sweet as glucose, is what distinguishes sugar from other carbohydrate-rich foods like bread or potatoes that break down upon digestion to glucose alone. The more fructose in a substance, the sweeter it will be. High-fructose corn syrup, as it is most commonly consumed, is 55 percent fructose, and the remaining 45 percent is nearly all glucose. It was first marketed in the late 1970s and was created to be indistinguishable from refined sugar when used in soft drinks. Because each of these sugars ends up as glucose and fructose in our guts, our bodies react the same way to both, and the physiological effects are identical. In a 2010 review of the relevant science, Luc Tappy, a researcher at the University of Lausanne in Switzerland who is considered by biochemists who study fructose to be the world’s foremost authority on the subject, said there was “not the single hint” that H.F.C.S. was more deleterious than other sources of sugar.

The question, then, isn’t whether high-fructose corn syrup is worse than sugar; it’s what do they do to us, and how do they do it? The conventional wisdom has long been that the worst that can be said about sugars of any kind is that they cause tooth decay and represent “empty calories” that we eat in excess because they taste so good.

By this logic, sugar-sweetened beverages (or H.F.C.S.-sweetened beverages, as the Sugar Association prefers they are called) are bad for us not because there’s anything particularly toxic about the sugar they contain but just because people consume too many of them.

Those organizations that now advise us to cut down on our sugar consumption — the Department of Agriculture, for instance, in its recent Dietary Guidelines for Americans, or the American Heart Association in guidelines released in September 2009 (of which Lustig was a co-author) — do so for this reason. Refined sugar and H.F.C.S. don’t come with any protein, vitamins, minerals, antioxidants or fiber, and so they either displace other more nutritious elements of our diet or are eaten over and above what we need to sustain our weight, and this is why we get fatter.

Whether the empty-calories argument is true, it’s certainly convenient. It allows everyone to assign blame for obesity and, by extension, diabetes — two conditions so intimately linked that some authorities have taken to calling them “diabesity” — to overeating of all foods, or underexercising, because a calorie is a calorie. “This isn’t about demonizing any industry,” as Michelle Obama said about her Let’s Move program to combat the epidemic of childhood obesity. Instead it’s about getting us — or our children — to move more and eat less, reduce our portion sizes, cut back on snacks.

Lustig’s argument, however, is not about the consumption of empty calories — and biochemists have made the same case previously, though not so publicly. It is that sugar has unique characteristics, specifically in the way the human body metabolizes the fructose in it, that may make it singularly harmful, at least if consumed in sufficient quantities.

The phrase Lustig uses when he describes this concept is “isocaloric but not isometabolic.” This means we can eat 100 calories of glucose (from a potato or bread or other starch) or 100 calories of sugar (half glucose and half fructose), and they will be metabolized differently and have a different effect on the body. The calories are the same, but the metabolic consequences are quite different.

The fructose component of sugar and H.F.C.S. is metabolized primarily by the liver, while the glucose from sugar and starches is metabolized by every cell in the body. Consuming sugar (fructose and glucose) means more work for the liver than if you consumed the same number of calories of starch (glucose). And if you take that sugar in liquid form — soda or fruit juices — the fructose and glucose will hit the liver more quickly than if you consume them, say, in an apple (or several apples, to get what researchers would call the equivalent dose of sugar). The speed with which the liver has to do its work will also affect how it metabolizes the fructose and glucose.

In animals, or at least in laboratory rats and mice, it’s clear that if the fructose hits the liver in sufficient quantity and with sufficient speed, the liver will convert much of it to fat. This apparently induces a condition known as insulin resistance, which is now considered the fundamental problem in obesity, and the underlying defect in heart disease and in the type of diabetes, type 2, that is common to obese and overweight individuals. It might also be the underlying defect in many cancers.

If what happens in laboratory rodents also happens in humans, and if we are eating enough sugar to make it happen, then we are in trouble.

The last time an agency of the federal government looked into the question of sugar and health in any detail was in 2005, in a report by the Institute of Medicine, a branch of the National Academies. The authors of the report acknowledged that plenty of evidence suggested that sugar could increase the risk of heart disease and diabetes — even raising LDL cholesterol, known as the “bad cholesterol”—– but did not consider the research to be definitive. There was enough ambiguity, they concluded, that they couldn’t even set an upper limit on how much sugar constitutes too much. Referring back to the 2005 report, an Institute of Medicine report released last fall reiterated, “There is a lack of scientific agreement about the amount of sugars that can be consumed in a healthy diet.” This was the same conclusion that the Food and Drug Administration came to when it last assessed the sugar question, back in 1986. The F.D.A. report was perceived as an exoneration of sugar, and that perception influenced the treatment of sugar in the landmark reports on diet and health that came after.

The Sugar Association and the Corn Refiners Association have alsoportrayed the 1986 F.D.A. report as clearing sugar of nutritional crimes, but what it concluded was actually something else entirely. To be precise, the F.D.A. reviewers said that other than its contribution to calories, “no conclusive evidence on sugars demonstrates a hazard to the general public when sugars are consumed at the levels that are now current.” This is another way of saying that the evidence by no means refuted the kinds of claims that Lustig is making now and other researchers were making then, just that it wasn’t definitive or unambiguous.

What we have to keep in mind, says Walter Glinsmann, the F.D.A. administrator who was the primary author on the 1986 report and who now is an adviser to the Corn Refiners Association, is that sugar and high-fructose corn syrup might be toxic, as Lustig argues, but so might any substance if it’s consumed in ways or in quantities that are unnatural for humans. The question is always at what dose does a substance go from being harmless to harmful? How much do we have to consume before this happens?

When Glinsmann and his F.D.A. co-authors decided no conclusive evidence demonstrated harm at the levels of sugar then being consumed, they estimated those levels at 40 pounds per person per year beyond what we might get naturally in fruits and vegetables — 40 pounds per person per year of “added sugars” as nutritionists now call them. This is 200 calories per day of sugar, which is less than the amount in a can and a half of Coca-Cola or two cups of apple juice. If that’s indeed all we consume, most nutritionists today would be delighted, including Lustig.

But 40 pounds per year happened to be 35 pounds less than what Department of Agriculture analysts said we were consuming at the time — 75 pounds per person per year — and the U.S.D.A. estimates are typically considered to be the most reliable. By the early 2000s, according to the U.S.D.A., we had increased our consumption to more than 90 pounds per person per year.

That this increase happened to coincide with the current epidemics of obesity and diabetes is one reason that it’s tempting to blame sugars — sucrose and high-fructose corn syrup — for the problem. In 1980, roughly one in seven Americans was obese, and almost six million were diabetic, and the obesity rates, at least, hadn’t changed significantly in the 20 years previously. By the early 2000s, when sugar consumption peaked, one in every three Americans was obese, and 14 million were diabetic.

This correlation between sugar consumption and diabetes is what defense attorneys call circumstantial evidence. It’s more compelling than it otherwise might be, though, because the last time sugar consumption jumped markedly in this country, it was also associated with a diabetes epidemic.

In the early 20th century, many of the leading authorities on diabetes in North America and Europe (including Frederick Banting, who shared the 1923 Nobel Prize for the discovery of insulin) suspected that sugar causes diabetes based on the observation that the disease was rare in populations that didn’t consume refined sugar and widespread in those that did. In 1924, Haven Emerson, director of the institute of public health at Columbia University, reported that diabetes deaths in New York City had increased as much as 15-fold since the Civil War years, and that deaths increased as much as fourfold in some U.S. cities between 1900 and 1920 alone. This coincided, he noted, with an equally significant increase in sugar consumption — almost doubling from 1890 to the early 1920s — with the birth and subsequent growth of the candy and soft-drink industries.

Emerson’s argument was countered by Elliott Joslin, a leading authority on diabetes, and Joslin won out. But his argument was fundamentally flawed. Simply put, it went like this: The Japanese eat lots of rice, and Japanese diabetics are few and far between; rice is mostly carbohydrate, which suggests that sugar, also a carbohydrate, does not cause diabetes. But sugar and rice are not identical merely because they’re both carbohydrates. Joslin could not know at the time that the fructose content of sugar affects how we metabolize it.

Joslin was also unaware that the Japanese ate little sugar. In the early 1960s, the Japanese were eating as little sugar as Americans were a century earlier, maybe less, which means that the Japanese experience could have been used to support the idea that sugar causes diabetes. Still, with Joslin arguing in edition after edition of his seminal textbook that sugar played no role in diabetes, it eventually took on the aura of undisputed truth.

Until Lustig came along, the last time an academic forcefully put forward the sugar-as-toxin thesis was in the 1970s, when John Yudkin, a leading authority on nutrition in the United Kingdom, published a polemic on sugar called “Sweet and Dangerous.” Through the 1960s Yudkin did a series of experiments feeding sugar and starch to rodents, chickens, rabbits, pigs and college students. He found that the sugar invariably raised blood levels of triglycerides (a technical term for fat), which was then, as now, considered a risk factor for heart disease. Sugar also raised insulin levels in Yudkin’s experiments, which linked sugar directly to type 2 diabetes. Few in the medical community took Yudkin’s ideas seriously, largely because he was also arguing that dietary fat and saturated fat were harmless. This set Yudkin’s sugar hypothesis directly against the growing acceptance of the idea, prominent to this day, that dietary fat was the cause of heart disease, a notion championed by the University of Minnesota nutritionist Ancel Keys.

A common assumption at the time was that if one hypothesis was right, then the other was most likely wrong. Either fat caused heart disease by raising cholesterol, or sugar did by raising triglycerides. “The theory that diets high in sugar are an important cause of atherosclerosis and heart disease does not have wide support among experts in the field, who say that fats and cholesterol are the more likely culprits,” as Jane E. Brody wrote in The Times in 1977.

At the time, many of the key observations cited to argue that dietary fat caused heart disease actually support the sugar theory as well. During the Korean War, pathologists doing autopsies on American soldiers killed in battle noticed that many had significant plaques in their arteries, even those who were still teenagers, while the Koreans killed in battle did not. The atherosclerotic plaques in the Americans were attributed to the fact that they ate high-fat diets and the Koreans ate low-fat. But the Americans were also eating high-sugar diets, while the Koreans, like the Japanese, were not.

In 1970, Keys published the results of a landmark study in nutrition known as the Seven Countries Study. Its results were perceived by the medical community and the wider public as compelling evidence that saturated-fat consumption is the best dietary predictor of heart disease. But sugar consumption in the seven countries studied was almost equally predictive. So it was possible that Yudkin was right, and Keys was wrong, or that they could both be right. The evidence has always been able to go either way.

European clinicians tended to side with Yudkin; Americans with Keys. The situation wasn’t helped, as one of Yudkin’s colleagues later told me, by the fact that “there was quite a bit of loathing” between the two nutritionists themselves. In 1971, Keys published an article attacking Yudkin and describing his evidence against sugar as “flimsy indeed.” He treated Yudkin as a figure of scorn, and Yudkin never managed to shake the portrayal.

By the end of the 1970s, any scientist who studied the potentially deleterious effects of sugar in the diet, according to Sheldon Reiser, who did just that at the U.S.D.A.’s Carbohydrate Nutrition Laboratory in Beltsville, Md., and talked about it publicly, was endangering his reputation. “Yudkin was so discredited,” Reiser said to me. “He was ridiculed in a way. And anybody else who said something bad about sucrose, they’d say, ‘He’s just like Yudkin.’ ”

What has changed since then, other than Americans getting fatter and more diabetic? It wasn’t so much that researchers learned anything particularly new about the effects of sugar or high-fructose corn syrup in the human body. Rather the context of the science changed: physicians and medical authorities came to accept the idea that a condition known as metabolic syndrome is a major, if not themajor, risk factor for heart disease and diabetes. The Centers for Disease Control and Prevention now estimate that some 75 million Americans have metabolic syndrome. For those who have heart attacks, metabolic syndrome will very likely be the reason.

The first symptom doctors are told to look for in diagnosing metabolic syndrome is an expanding waistline. This means that if you’re overweight, there’s a good chance you have metabolic syndrome, and this is why you’re more likely to have a heart attack or become diabetic (or both) than someone who’s not. Although lean individuals, too, can have metabolic syndrome, and they are at greater risk of heart disease and diabetes than lean individuals without it.

Having metabolic syndrome is another way of saying that the cells in your body are actively ignoring the action of the hormone insulin — a condition known technically as being insulin-resistant. Because insulin resistance and metabolic syndrome still get remarkably little attention in the press (certainly compared with cholesterol), let me explain the basics.

You secrete insulin in response to the foods you eat — particularly the carbohydrates — to keep blood sugar in control after a meal. When your cells are resistant to insulin, your body (your pancreas, to be precise) responds to rising blood sugar by pumping out more and more insulin. Eventually the pancreas can no longer keep up with the demand or it gives in to what diabetologists call “pancreatic exhaustion.” Now your blood sugar will rise out of control, and you’ve got diabetes.

Not everyone with insulin resistance becomes diabetic; some continue to secrete enough insulin to overcome their cells’ resistance to the hormone. But having chronically elevated insulin levels has harmful effects of its own — heart disease, for one. A result is higher triglyceride levels and blood pressure, lower levels of HDL cholesterol (the “good cholesterol”), further worsening the insulin resistance — this is metabolic syndrome.

When physicians assess your risk of heart disease these days, they will take into consideration your LDL cholesterol (the bad kind), but also these symptoms of metabolic syndrome. The idea, according to Scott Grundy, a University of Texas Southwestern Medical Center nutritionist and the chairman of the panel that produced the last edition of the National Cholesterol Education Program guidelines, is that heart attacks 50 years ago might have been caused by high cholesterol — particularly high LDL cholesterol — but since then we’ve all gotten fatter and more diabetic, and now it’s metabolic syndrome that’s the more conspicuous problem.

This raises two obvious questions. The first is what sets off metabolic syndrome to begin with, which is another way of asking, What causes the initial insulin resistance? There are several hypotheses, but researchers who study the mechanisms of insulin resistance now think that a likely cause is the accumulation of fat in the liver. When studies have been done trying to answer this question in humans, says Varman Samuel, who studies insulin resistance at Yale School of Medicine, the correlation between liver fat and insulin resistance in patients, lean or obese, is “remarkably strong.” What it looks like, Samuel says, is that “when you deposit fat in the liver, that’s when you become insulin-resistant.”

That raises the other obvious question: What causes the liver to accumulate fat in humans? A common assumption is that simply getting fatter leads to a fatty liver, but this does not explain fatty liver in lean people. Some of it could be attributed to genetic predisposition. But harking back to Lustig, there’s also the very real possibility that it is caused by sugar.

As it happens, metabolic syndrome and insulin resistance are the reasons that many of the researchers today studying fructose became interested in the subject to begin with. If you want to cause insulin resistance in laboratory rats, says Gerald Reaven, the Stanford University diabetologist who did much of the pioneering work on the subject, feeding them diets that are mostly fructose is an easy way to do it. It’s a “very obvious, very dramatic” effect, Reaven says.

By the early 2000s, researchers studying fructose metabolism had established certain findings unambiguously and had well-established biochemical explanations for what was happening. Feed animals enough pure fructose or enough sugar, and their livers convert the fructose into fat — the saturated fatty acid, palmitate, to be precise, that supposedly gives us heart disease when we eat it, by raising LDL cholesterol. The fat accumulates in the liver, and insulin resistance and metabolic syndrome follow.

Michael Pagliassotti, a Colorado State University biochemist who did many of the relevant animal studies in the late 1990s, says these changes can happen in as little as a week if the animals are fed sugar or fructose in huge amounts — 60 or 70 percent of the calories in their diets. They can take several months if the animals are fed something closer to what humans (in America) actually consume — around 20 percent of the calories in their diet. Stop feeding them the sugar, in either case, and the fatty liver promptly goes away, and with it the insulin resistance.

Similar effects can be shown in humans, although the researchers doing this work typically did the studies with only fructose — as Luc Tappy did in Switzerland or Peter Havel and Kimber Stanhope did at the University of California, Davis — and pure fructose is not the same thing as sugar or high-fructose corn syrup. When Tappy fed his human subjects the equivalent of the fructose in 8 to 10 cans of Coke or Pepsi a day — a “pretty high dose,” he says —– their livers would start to become insulin-resistant, and their triglycerides would go up in just a few days. With lower doses, Tappy says, just as in the animal research, the same effects would appear, but it would take longer, a month or more.

Despite the steady accumulation of research, the evidence can still be criticized as falling far short of conclusive. The studies in rodents aren’t necessarily applicable to humans. And the kinds of studies that Tappy, Havel and Stanhope did — having real people drink beverages sweetened with fructose and comparing the effect with what happens when the same people or others drink beverages sweetened with glucose — aren’t applicable to real human experience, because we never naturally consume pure fructose. We always take it with glucose, in the nearly 50-50 combinations of sugar or high-fructose corn syrup. And then the amount of fructose or sucrose being fed in these studies, to the rodents or the human subjects, has typically been enormous.

This is why the research reviews on the subject invariably conclude that more research is necessary to establish at what dose sugar and high-fructose corn syrup start becoming what Lustig calls toxic. “There is clearly a need for intervention studies,” as Tappy recently phrased it in the technical jargon of the field, “in which the fructose intake of high-fructose consumers is reduced to better delineate the possible pathogenic role of fructose. At present, short-term-intervention studies, however, suggest that a high-fructose intake consisting of soft drinks, sweetened juices or bakery products can increase the risk of metabolic and cardiovascular diseases.”

In simpler language, how much of this stuff do we have to eat or drink, and for how long, before it does to us what it does to laboratory rats? And is that amount more than we’re already consuming?

Unfortunately, we’re unlikely to learn anything conclusive in the near future. As Lustig points out, sugar and high-fructose corn syrup are certainly not “acute toxins” of the kind the F.D.A. typically regulates and the effects of which can be studied over the course of days or months. The question is whether they’re “chronic toxins,” which means “not toxic after one meal, but after 1,000 meals.” This means that what Tappy calls “intervention studies” have to go on for significantly longer than 1,000 meals to be meaningful.

At the moment, the National Institutes of Health are supporting surprisingly few clinical trials related to sugar and high-fructose corn syrup in the U.S. All are small, and none will last more than a few months. Lustig and his colleagues at U.C.S.F. — including Jean-Marc Schwarz, whom Tappy describes as one of the three best fructose biochemists in the world — are doing one of these studies. It will look at what happens when obese teenagers consume no sugar other than what they might get in fruits and vegetables. Another study will do the same with pregnant women to see if their babies are born healthier and leaner.

Only one study in this country, by Havel and Stanhope at the University of California, Davis, is directly addressing the question of how much sugar is required to trigger the symptoms of insulin resistance and metabolic syndrome. Havel and Stanhope are having healthy people drink three sugar- or H.F.C.S.-sweetened beverages a day and then seeing what happens. The catch is that their study subjects go through this three-beverage-a-day routine for only two weeks. That doesn’t seem like a very long time — only 42 meals, not 1,000 — but Havel and Stanhope have been studying fructose since the mid-1990s, and they seem confident that two weeks is sufficient to see if these sugars cause at least some of the symptoms of metabolic syndrome.

So the answer to the question of whether sugar is as bad as Lustig claims is that it certainly could be. It very well may be true that sugar and high-fructose corn syrup, because of the unique way in which we metabolize fructose and at the levels we now consume it, cause fat to accumulate in our livers followed by insulin resistance and metabolic syndrome, and so trigger the process that leads to heart disease, diabetes and obesity. They could indeed be toxic, but they take years to do their damage. It doesn’t happen overnight. Until long-term studies are done, we won’t know for sure.

One more question still needs to be asked, and this is what my wife, who has had to live with my journalistic obsession on this subject, calls the Grinch-trying-to-steal-Christmas problem. What are the chances that sugar is actually worse than Lustig says it is?

One of the diseases that increases in incidence with obesity, diabetes and metabolic syndrome is cancer. This is why I said earlier that insulin resistance may be a fundamental underlying defect in many cancers, as it is in type 2 diabetes and heart disease. The connection between obesity, diabetes and cancer was first reported in 2004 in large population studies by researchers from the World Health Organization’s International Agency for Research on Cancer. It is not controversial. What it means is that you are more likely to get cancer if you’re obese or diabetic than if you’re not, and you’re more likely to get cancer if you have metabolic syndrome than if you don’t.

This goes along with two other observations that have led to the well-accepted idea that some large percentage of cancers are caused by our Western diets and lifestyles. This means they could actually be prevented if we could pinpoint exactly what the problem is and prevent or avoid that.

One observation is that death rates from cancer, like those from diabetes, increased significantly in the second half of the 19th century and the early decades of the 20th. As with diabetes, this observation was accompanied by a vigorous debate about whether those increases could be explained solely by the aging of the population and the use of new diagnostic techniques or whether it was really the incidence of cancer itself that was increasing. “By the 1930s,” as a 1997 report by the World Cancer Research Fund International and the American Institute for Cancer Research explained, “it was apparent that age-adjusted death rates from cancer were rising in the U.S.A.,” which meant that the likelihood of any particular 60-year-old, for instance, dying from cancer was increasing, even if there were indeed more 60-years-olds with each passing year.

The second observation was that malignant cancer, like diabetes, was a relatively rare disease in populations that didn’t eat Western diets, and in some of these populations it appeared to be virtually nonexistent. In the 1950s, malignant cancer among the Inuit, for instance, was still deemed sufficiently rare that physicians working in northern Canada would publish case reports in medical journals when they did diagnose a case.

In 1984, Canadian physicians published an analysis of 30 years of cancer incidence among Inuit in the western and central Arctic. While there had been a “striking increase in the incidence of cancers of modern societies” including lung and cervical cancer, they reported, there were still “conspicuous deficits” in breast-cancer rates. They could not find a single case in an Inuit patient before 1966; they could find only two cases between 1967 and 1980. Since then, as their diet became more like ours, breast cancer incidence has steadily increased among the Inuit, although it’s still significantly lower than it is in other North American ethnic groups. Diabetes rates in the Inuit have also gone from vanishingly low in the mid-20th century to high today.

Now most researchers will agree that the link between Western diet or lifestyle and cancer manifests itself through this association with obesity, diabetes and metabolic syndrome — i.e., insulin resistance. This was the conclusion, for instance, of a 2007 report published by the World Cancer Research Fund and the American Institute for Cancer Research — “Food, Nutrition, Physical Activity and the Prevention of Cancer.”

So how does it work? Cancer researchers now consider that the problem with insulin resistance is that it leads us to secrete more insulin, and insulin (as well as a related hormone known as insulin-like growth factor) actually promotes tumor growth.

As it was explained to me by Craig Thompson, who has done much of this research and is now president of Memorial Sloan-Kettering Cancer Center in New York, the cells of many human cancers come to depend on insulin to provide the fuel (blood sugar) and materials they need to grow and multiply. Insulin and insulin-like growth factor (and related growth factors) also provide the signal, in effect, to do it. The more insulin, the better they do. Some cancers develop mutations that serve the purpose of increasing the influence of insulin on the cell; others take advantage of the elevated insulin levels that are common to metabolic syndrome, obesity and type 2 diabetes. Some do both. Thompson believes that many pre-cancerous cells would never acquire the mutations that turn them into malignant tumors if they weren’t being driven by insulin to take up more and more blood sugar and metabolize it.

What these researchers call elevated insulin (or insulin-like growth factor) signaling appears to be a necessary step in many human cancers, particularly cancers like breast and colon cancer. Lewis Cantley, director of the Cancer Center at Beth Israel Deaconess Medical Center at Harvard Medical School, says that up to 80 percent of all human cancers are driven by either mutations or environmental factors that work to enhance or mimic the effect of insulin on the incipient tumor cells. Cantley is now the leader of one of five scientific “dream teams,” financed by a national coalition called Stand Up to Cancer, to study, in the case of Cantley’s team, precisely this link between a specific insulin-signaling gene (known technically as PI3K) and tumor development in breast and other cancers common to women.

Most of the researchers studying this insulin/cancer link seem concerned primarily with finding a drug that might work to suppress insulin signaling in incipient cancer cells and so, they hope, inhibit or prevent their growth entirely. Many of the experts writing about the insulin/cancer link from a public health perspective — as in the 2007 report from the World Cancer Research Fund and the American Institute for Cancer Research — work from the assumption that chronically elevated insulin levels and insulin resistance are both caused by being fat or by getting fatter. They recommend, as the 2007 report did, that we should all work to be lean and more physically active, and that in turn will help us prevent cancer.

But some researchers will make the case, as Cantley and Thompson do, that if something other than just being fatter is causing insulin resistance to begin with, that’s quite likely the dietary cause of many cancers. If it’s sugar that causes insulin resistance, they say, then the conclusion is hard to avoid that sugar causes cancer — some cancers, at least — radical as this may seem and despite the fact that this suggestion has rarely if ever been voiced before publicly. For just this reason, neither of these men will eat sugar or high-fructose corn syrup, if they can avoid it.

“I have eliminated refined sugar from my diet and eat as little as I possibly can,” Thompson told me, “because I believe ultimately it’s something I can do to decrease my risk of cancer.” Cantley put it this way: “Sugar scares me.”

Sugar scares me too, obviously. I’d like to eat it in moderation. I’d certainly like my two sons to be able to eat it in moderation, to not overconsume it, but I don’t actually know what that means, and I’ve been reporting on this subject and studying it for more than a decade. If sugar just makes us fatter, that’s one thing. We start gaining weight, we eat less of it. But we are also talking about things we can’t see — fatty liver, insulin resistance and all that follows. Officially I’m not supposed to worry because the evidence isn’t conclusive, but I do.

Gary Taubes (gataubes@gmail.com) is a Robert Wood Johnson Foundation independent investigator in health policy and the author of “Why We Get Fat.” Editor: Vera Titunik (v.titunik-MagGroup@nytimes.com).